MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
equity securities, net
$5,861,483
Net cash provided by
(used in) provided by...
$5,861,483
Net decrease in cash
and cash...
$4,014,794
Canceled cashflow
$1,846,689
Equity-based compensation
expense
$22,846
Accrued expenses and
other current...
$4,230
Depreciation and
amortization
$1,106
Net cash used in
operating activities
-$1,646,689
Net cash used in
investing activities
-$200,000
Canceled cashflow
$28,182
Net loss
-$873,467
Prepaid expenses and
other assets
$490,565
Accounts payable
-$310,839
Short term promissory
note
$200,000
Back
Back
Cash Flow
source: myfinsight.com
Salarius Pharmaceuticals, Inc. (SLRX)
Salarius Pharmaceuticals, Inc. (SLRX)